PSMB8 and plasma cell myeloma: PSMB8 activity is also affected by Bortezomib [76]; however, Shi et al., in 2020, created proteasome subunit-knockout myeloma cell lines and concluded that knocking out PSMB8 did not resensitize the cells to Bortezomib [72].